202 related articles for article (PubMed ID: 34995415)
1. Off-target inhibition of NGLY1 by the polycaspase inhibitor Z-VAD-fmk induces cellular autophagy.
Needs SH; Bootman MD; Grotzke JE; Kramer HB; Allman SA
FEBS J; 2022 Jun; 289(11):3115-3131. PubMed ID: 34995415
[TBL] [Abstract][Full Text] [Related]
2. The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions.
Suzuki T; Huang C; Fujihira H
Gene; 2016 Feb; 577(1):1-7. PubMed ID: 26611529
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.
Miao X; Wu J; Chen H; Lu G
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565658
[TBL] [Abstract][Full Text] [Related]
4. Physiological importance of NGLY1, as revealed by rodent model analyses.
Fujihira H; Asahina M; Suzuki T
J Biochem; 2022 Feb; 171(2):161-167. PubMed ID: 34580715
[TBL] [Abstract][Full Text] [Related]
5. N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity.
Tambe MA; Ng BG; Freeze HH
Cell Rep; 2019 Dec; 29(13):4620-4631.e4. PubMed ID: 31875565
[TBL] [Abstract][Full Text] [Related]
6. Endo-β-N-acetylglucosaminidase forms N-GlcNAc protein aggregates during ER-associated degradation in Ngly1-defective cells.
Huang C; Harada Y; Hosomi A; Masahara-Negishi Y; Seino J; Fujihira H; Funakoshi Y; Suzuki T; Dohmae N; Suzuki T
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1398-403. PubMed ID: 25605922
[TBL] [Abstract][Full Text] [Related]
7. z-VAD-fmk inhibits peptide:N-glycanase and may result in ER stress.
Misaghi S; Korbel GA; Kessler B; Spooner E; Ploegh HL
Cell Death Differ; 2006 Jan; 13(1):163-5. PubMed ID: 16003388
[No Abstract] [Full Text] [Related]
8. The cytoplasmic peptide:N-glycanase (Ngly1)-basic science encounters a human genetic disorder.
Suzuki T
J Biochem; 2015 Jan; 157(1):23-34. PubMed ID: 25398991
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cells.
Hetz R; Magaway C; Everett J; Li L; Willard BB; Freeze HH; He P
Biochem Biophys Res Commun; 2022 Dec; 632():165-172. PubMed ID: 36209585
[TBL] [Abstract][Full Text] [Related]
10. Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell Lines.
Mueller WF; Jakob P; Sun H; Clauder-Münster S; Ghidelli-Disse S; Ordonez D; Boesche M; Bantscheff M; Collier P; Haase B; Benes V; Paulsen M; Sehr P; Lewis J; Drewes G; Steinmetz LM
G3 (Bethesda); 2020 May; 10(5):1585-1597. PubMed ID: 32265286
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
Owings KG; Lowry JB; Bi Y; Might M; Chow CY
Hum Mol Genet; 2018 Mar; 27(6):1055-1066. PubMed ID: 29346549
[TBL] [Abstract][Full Text] [Related]
12. Ever-expanding NGLY1 biology.
Suzuki T; Yoshida Y
J Biochem; 2022 Feb; 171(2):141-143. PubMed ID: 34969094
[TBL] [Abstract][Full Text] [Related]
13. Development of a fluorescence and quencher-based FRET assay for detection of endogenous peptide:N-glycanase/NGLY1 activity.
Hirayama H; Tachida Y; Fujinawa R; Matsuda Y; Murase T; Nishiuchi Y; Suzuki T
J Biol Chem; 2024 Apr; 300(4):107121. PubMed ID: 38417795
[TBL] [Abstract][Full Text] [Related]
14. A method for assaying peptide: N-glycanase/N-glycanase 1 activities in crude extracts using an N-glycosylated cyclopeptide.
Hirayama H; Tachida Y; Seino J; Suzuki T
Glycobiology; 2022 Mar; 32(2):110-122. PubMed ID: 34939090
[TBL] [Abstract][Full Text] [Related]
15. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress.
Fujihira H; Masahara-Negishi Y; Akimoto Y; Hirayama H; Lee HC; Story BA; Mueller WF; Jakob P; Clauder-Münster S; Steinmetz LM; Radhakrishnan SK; Kawakami H; Kamada Y; Miyoshi E; Yokomizo T; Suzuki T
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165588. PubMed ID: 31733337
[TBL] [Abstract][Full Text] [Related]
16. A Natural Compound Containing a Disaccharide Structure of Glucose and Rhamnose Identified as Potential N-Glycanase 1 (NGLY1) Inhibitors.
Liu R; Gu J; Ye Y; Zhang Y; Zhang S; Lin Q; Yuan S; Chen Y; Lu X; Tong Y; Lv S; Chen L; Sun G
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067490
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of N-glycanase 1 perturbs neurogenesis and cerebral development modeled by human organoids.
Lin VJT; Hu J; Zolekar A; Salick MR; Mittal P; Bird JT; Hoffmann P; Kaykas A; Byrum SD; Wang YC
Cell Death Dis; 2022 Mar; 13(3):262. PubMed ID: 35322011
[TBL] [Abstract][Full Text] [Related]
18. Cellular autophagy, an unbidden effect of caspase inhibition by zVAD-fmk.
Sakthivel D; Bolívar BE; Bouchier-Hayes L
FEBS J; 2022 Jun; 289(11):3097-3100. PubMed ID: 35043564
[TBL] [Abstract][Full Text] [Related]
19. New perspectives on the mutated NGLY1 enigma.
Tickotsky-Moskovitz N
Med Hypotheses; 2015 Nov; 85(5):584-5. PubMed ID: 26228302
[TBL] [Abstract][Full Text] [Related]
20. Fluorescently labeled inhibitor for profiling cytoplasmic peptide:N-glycanase.
Hagihara S; Miyazaki A; Matsuo I; Tatami A; Suzuki T; Ito Y
Glycobiology; 2007 Oct; 17(10):1070-6. PubMed ID: 17640972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]